News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,646 Results
Type
Article (41438)
Company Profile (263)
Press Release (690931)
Multimedia
Podcasts (94)
Webinars (20)
Section
Business (204878)
Career Advice (2034)
Deals (35602)
Drug Delivery (132)
Drug Development (81561)
Employer Resources (173)
FDA (16522)
Job Trends (14991)
News (346916)
Policy (32751)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2603)
Accelerated approval (53)
Adcomms (27)
Allergies (176)
Alliances (49581)
ALS (218)
Alzheimer's disease (1811)
Antibody-drug conjugate (ADC) (490)
Approvals (16944)
Artificial intelligence (691)
Autoimmune disease (317)
Automation (58)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (227)
Biotechnology (170)
Bladder cancer (200)
Brain cancer (73)
Breast cancer (783)
Cancer (6098)
Cardiovascular disease (486)
Career advice (1729)
Career pathing (44)
CAR-T (345)
CDC (57)
Celiac Disease (3)
Cell therapy (932)
Cervical cancer (51)
Clinical research (71175)
Collaboration (2119)
Company closure (5)
Compensation (1447)
Complete response letters (82)
COVID-19 (2749)
CRISPR (111)
C-suite (1169)
Cystic fibrosis (154)
Data (8318)
Decentralized trials (3)
Denatured (28)
Depression (165)
Dermatology (93)
Diabetes (613)
Diagnostics (6986)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (334)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (292)
Earnings (92171)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (120172)
Executive appointments (1098)
FDA (20364)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1771)
Gene editing (238)
Generative AI (59)
Gene therapy (732)
GLP-1 (1063)
Government (4740)
Grass and pollen (6)
Guidances (414)
Healthcare (19123)
HIV (82)
Huntington's disease (57)
IgA nephropathy (109)
Immunology and inflammation (291)
Immuno-oncology (99)
Indications (200)
Infectious disease (3103)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (302)
Interviews (320)
IPO (16670)
IRA (50)
Job creations (3649)
Job search strategy (1431)
JPM (58)
Kidney cancer (20)
Labor market (107)
Layoffs (567)
Leadership (41)
Legal (7953)
Liver cancer (102)
Longevity (33)
Lung cancer (815)
Lymphoma (449)
Machine learning (60)
Management (59)
Manufacturing (1090)
MASH (200)
Medical device (13956)
Medtech (14098)
Mergers & acquisitions (20199)
Metabolic disorders (1556)
mRNA (217)
Multiple sclerosis (193)
NASH (17)
Neurodegenerative disease (435)
Neuropsychiatric disorders (106)
Neuroscience (3378)
Neurotech (1)
NextGen: Class of 2026 (6522)
Non-profit (4533)
Now hiring (79)
Obesity (721)
Opinion (291)
Ovarian cancer (233)
Pain (258)
Pancreatic cancer (327)
Parkinson's disease (378)
Partnered (33)
Patents (611)
Patient recruitment (698)
Peanut (64)
People (59710)
Pharmaceutical (58)
Pharmacy benefit managers (33)
Phase 1 (22195)
Phase 2 (31357)
Phase 3 (23330)
Pipeline (9292)
Policy (323)
Postmarket research (2569)
Preclinical (9436)
Press Release (64)
Prostate cancer (323)
Psychedelics (54)
Radiopharmaceuticals (337)
Rare diseases (1107)
Real estate (5973)
Recruiting (70)
Regulatory (25572)
Reports (56)
Research institute (2417)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (23)
RSV (88)
Schizophrenia (179)
Series A (297)
Series B (217)
Service/supplier (11)
Sickle cell disease (117)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3644)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (87)
The Weekly (64)
Vaccines (1119)
Venture capital (114)
Weight loss (460)
Women's health (130)
Worklife (20)
Date
Today (73)
Last 7 days (727)
Last 30 days (3247)
Last 365 days (30236)
2026 (14405)
2025 (30169)
2024 (35208)
2023 (40072)
2022 (51174)
2021 (55706)
2020 (54081)
2019 (46535)
2018 (35015)
2017 (32106)
2016 (31479)
2015 (37551)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (354)
Arkansas (14)
Asia (39803)
Australia (6527)
California (13667)
Canada (3855)
China (1419)
Colorado (580)
Connecticut (597)
Delaware (422)
Europe (86136)
Florida (2044)
Georgia (438)
Hawaii (3)
Idaho (63)
Illinois (1103)
India (93)
Indiana (617)
Iowa (23)
Japan (562)
Kansas (132)
Kentucky (50)
Louisiana (44)
Maine (76)
Maryland (1633)
Massachusetts (9764)
Michigan (370)
Minnesota (738)
Mississippi (6)
Missouri (146)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (84)
New Jersey (3579)
New Mexico (30)
New York (3578)
North Carolina (1724)
North Dakota (9)
Northern California (6881)
Ohio (408)
Oklahoma (23)
Oregon (41)
Pennsylvania (2736)
Puerto Rico (29)
Rhode Island (51)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5407)
Tennessee (217)
Texas (2177)
United States (48155)
Utah (405)
Vermont (1)
Virginia (329)
Washington D.C. (81)
Washington State (1092)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
732,646 Results for "terarecon inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ConcertAI’s TeraRecon and Avicenna.AI Partner on AI for Incidental Pulmonary Embolism
ConcertAI’s TeraRecon, the advanced visualization and AI Clinical SaaS category leader, today announced a partnership to offer medical imaging AI specialist Avicenna.AI’s CINA-iPE solution detecting the presence of incidental pulmonary embolisms as part of TeraRecon’s Eureka Clinical AI solution.
March 13, 2023
·
3 min read
Genetown
ConcertAI’s TeraRecon Expands AI Model and Clinical Collaboration Capabilities of Eureka Clinical AI
ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, announced the launch of its enhanced, next-generation Eureka Clinical AI platform.
May 8, 2023
·
4 min read
Genetown
ConcertAI’s TeraRecon Adds the Releases of an AI-Assisted Clinical Suite Solution, Neuro Suite to Provide Comprehensive Solutions for Neurological Disorders
ConcertAI’s TeraRecon has announced the release of its AI-driven clinical suite, Neuro Suite.
April 28, 2023
·
3 min read
Press Releases
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 4, 2026
·
3 min read
Genetown
ConcertAI’s TeraRecon Inks Distribution Deals with Seven AI Developers Alongside EU Launch of Eureka Clinical AI Platform at #ECR23
ConcertAI’s TeraRecon has announced its Eureka Clinical AI platform is now available to European healthcare providers.
February 27, 2023
·
5 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
June 3, 2026
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
June 3, 2026
·
5 min read
Press Releases
SGS Expands Bioanalytical Testing Capabilities in North America with Acquisition of CMIC, INC.
June 4, 2026
·
3 min read
Press Releases
OrthAlign, Inc. Receives FDA 510(k) clearance for the Lantern® ASC system
June 3, 2026
·
3 min read
Press Releases
Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032
June 3, 2026
·
8 min read
1 of 73,265
Next
